Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

TAVR in low-risk patients holds steady at 2 years

Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery in low-risk patients with severe aortic stenosis, based on two-year results presented May 19 at EuroPCR in Paris.

Thumbnail

Get ready for SCAI, HRS

This is the month for subspecialty cardiology conferences in the U.S., with two major meetings setting anchors on each coast.

Prairie Heart Institute breaks a record: First cath lab in Illinois to achieve ACE accreditation

The Prairie Heart Institute at St. John's Hospital in Springfield, Illinois, has become the first cardiac catheterization laboratory in Illinois to achieve ACE accreditation. It is also one of the highest volume facilities to achieve this notable accomplishment.

Thumbnail

VIVA.14: Promising 1-year results for drug-coated balloons in diabetics

Patients with peripheral artery disease (PAD) and diabetes who underwent treatment with a drug-coated balloon fared better than counterparts who received standard care, according to a subanalysis of the IN.PACT SFA trial.

VIVA.14: Zilver PTX holds strong at five years

At five years, the Zilver PTX stent proved to be a durable treatment for peripheral artery disease with sustained benefit, results presented Nov. 4 at the 2014 Vascular Interventional Advances (VIVA) meeting showed.

Thumbnail

VIVA.14: DISRUPT PAD brings lithoplasty technique to peripheral lesions

Shockwaves appear to have early success in breaking up calcified lesions safely. In research presented Nov. 5 at the 2014 Vascular Interventional Advances (VIVA) meeting in Las Vegas, a lithotripsy-with-balloon technique used on peripheral artery lesions resulted in all patients achieving less than 50 percent stenosis. 

Covidien announces 12-month DEFINITIVE AR results at VIVA 2014

Covidien announced 12-month results of the DEFINITIVE AR study, the first randomized study designed to identify the clinical benefits of plaque removal using directional atherectomy followed by drug coated balloon. The results were presented by Professor Thomas Zeller of the Universitaets-Herzzentrum, Bad Krozingen, Germany at the Vascular Interventional Advances (VIVA) 2014 conference in Las Vegas, Nev.

GE Healthcare installs Cath Lab Efficiency Manager, a new IT solution to improve performance measurement in the interventional lab

GE Healthcare has installed Cath Lab Efficiency Manager at Saint Luke’s Mid America Heart Institute in Kansas City, MO , a new analytical tool that analyzes the performance of an interventional lab providing hospitals with important data they can use to identify areas of improvement.  Cath Lab Efficiency Manager provides a near-real-time dashboard which displays measures of inefficiency and identifies the factors impacting performance. The tool visualizes where changes can be made to help increase productivity and help improve patient care.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup